Heart Attack

Elucid Names Kelly Huang as CEOElucid Names Kelly Huang as CEO

Elucid Names Kelly Huang as CEO

Experienced commercial leader takes helm to expand cardiovascular diagnostic company globally and commercialize company’s flagship plaque analysis softwareBOSTON--(BUSINESS WIRE)--Elucid, a…

10 months ago
Baptist Health Breaks Ground On Third Combined ER and Urgent Care FacilityBaptist Health Breaks Ground On Third Combined ER and Urgent Care Facility

Baptist Health Breaks Ground On Third Combined ER and Urgent Care Facility

Innovative Facility on Bardstown Road Continues Expansion of Patient-First Healthcare ModelLOUISVILLE, KY / ACCESSWIRE / July 18, 2024 / Baptist…

11 months ago
Viome Launches the First Personalized AM/PM Toothpaste & Gel Formulated Using Oral Microbiome Data and AI to Support Whole-body HealthViome Launches the First Personalized AM/PM Toothpaste & Gel Formulated Using Oral Microbiome Data and AI to Support Whole-body Health

Viome Launches the First Personalized AM/PM Toothpaste & Gel Formulated Using Oral Microbiome Data and AI to Support Whole-body Health

This groundbreaking product fulfills an unmet oral health market need, surpassing traditional toothpaste's benefits and focusing on underlying causes of…

11 months ago
Element Science Receives Prestigious International Red Dot Design Award for Innovative Jewel® Patch Wearable Cardioverter DefibrillatorElement Science Receives Prestigious International Red Dot Design Award for Innovative Jewel® Patch Wearable Cardioverter Defibrillator

Element Science Receives Prestigious International Red Dot Design Award for Innovative Jewel® Patch Wearable Cardioverter Defibrillator

Novel technology recognized for its groundbreaking design and patient-centric innovationSAN FRANCISCO--(BUSINESS WIRE)--Element Science, an innovative health technology company pioneering a…

11 months ago
CellProthera and BioCardia Collaborate on Successful Phase II Trial of ProtheraCytes™ for the Treatment of Acute Myocardial InfarctionCellProthera and BioCardia Collaborate on Successful Phase II Trial of ProtheraCytes™ for the Treatment of Acute Myocardial Infarction

CellProthera and BioCardia Collaborate on Successful Phase II Trial of ProtheraCytes™ for the Treatment of Acute Myocardial Infarction

MULHOUSE, France, and SUNNYVALE, Calif., July 08, 2024 (GLOBE NEWSWIRE) -- CellProthera, a private company specializing in cell-based therapies for…

11 months ago
AliveCor Announces Dual FDA Clearance of AI Technology That Delivers 35 Cardiac Determinations and First-of-its-Kind Kardia 12L ECG SystemAliveCor Announces Dual FDA Clearance of AI Technology That Delivers 35 Cardiac Determinations and First-of-its-Kind Kardia 12L ECG System

AliveCor Announces Dual FDA Clearance of AI Technology That Delivers 35 Cardiac Determinations and First-of-its-Kind Kardia 12L ECG System

World's First AI to Detect 35 Cardiac Determinations, Including Heart Attack, Using a Reduced Leadset Powered by this AI, the…

11 months ago
Erie County Medical Center Leverages Brook Health’s AI and Remote Care Platform to Transform Hypertension ManagementErie County Medical Center Leverages Brook Health’s AI and Remote Care Platform to Transform Hypertension Management

Erie County Medical Center Leverages Brook Health’s AI and Remote Care Platform to Transform Hypertension Management

Collaboration Doubles Blood Pressure Control for High-Risk Patients in 12 Weeks BUFFALO, N.Y., June 25, 2024 /PRNewswire/ -- Brook Health,…

11 months ago
Single-Cell Functional Profiling Using Nanovial Technology Unveils the Therapeutic Potential of Extracellular VesiclesSingle-Cell Functional Profiling Using Nanovial Technology Unveils the Therapeutic Potential of Extracellular Vesicles

Single-Cell Functional Profiling Using Nanovial Technology Unveils the Therapeutic Potential of Extracellular Vesicles

LOS ANGELES, June 18, 2024 /PRNewswire/ -- Partillion Bioscience Corporation ("Partillion"), a life science tools company, announced a new publication…

12 months ago
Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS)Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS)

Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS)

Gap in non-oral prescriptions relative to AHS guidelines represents an opportunity to increase awareness of Tonix’s two FDA-approved non-oral treatments…

12 months ago